Comparative analysis of 2022 outbreak MPXV and previous clade II MPXV

The 2022–2024 outbreak of MPOX is an important worldwide public health issue that has triggered significant concerns in the scientific community. MPOX is caused by monkeypox virus (MPXV) belonging to the Poxviridae family. The study of MPXV presents a multifaceted challenge due to the diverse viral...

Descripción completa

Detalles Bibliográficos
Autores: McGrail, Joseph Patrick, Paniz-Mondolfi, Alberto, Ramírez, Juan David, Vidal Freire, Santiago, Garcia-Sastre, Adolfo, Palacios, Gustavo, Sánchez-Seco, María Paz, Guerra García, María Susana
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universidad Autónoma de Madrid
Repositorio:Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:inglés
OAI Identifier:oai:repositorio.uam.es:10486/716016
Acceso en línea:http://hdl.handle.net/10486/716016
https://dx.doi.org/10.1002/jmv.70023
Access Level:acceso abierto
Palabra clave:Clade II
EV
MPOX disease
MPXV
MV
Medicina
Descripción
Sumario:The 2022–2024 outbreak of MPOX is an important worldwide public health issue that has triggered significant concerns in the scientific community. MPOX is caused by monkeypox virus (MPXV) belonging to the Poxviridae family. The study of MPXV presents a multifaceted challenge due to the diverse viral form. This study was supported by ISIDORe consortium and Agencia Estatal de Investigación.s produced by this pathogen. Notably the intracellular mature viruses (MVs) primarily contribute to localized lesions and host‐to‐host transmission, while the extracellular enveloped viruses (EVs) are associated with systemic infection. Clinically, MPOX manifests as a vesiculopustular rash that initially emerges on the face and trunk, subsequently spreading throughout the body, with heightened severity observed in immunocompromised individuals. Results obtained in this manuscript indicate that the 2022 outbreak MPXV has a significantly slower viral cycle compared with previous Clade II strains,with WRAIR 7‐61 being more intermediate and USA 2003 producing highest viral titers. Additionally, proteomic and phospho‐proteomic analysis displays differences in protein expression between these three strains. These findings highlight key dif-ferences between the current Lineage B.1 MPXV and previous strains. Further studies will be undertaken to demonstrate if these differences are important for the apparent increased human‐to‐human transmission mechanisms observed in the CladeIIb MPXV outbreak